Literature DB >> 4277032

The reactivation of the proscillaridin-inhibited membrane ATPase by specific antibodies.

U R Kleeberg, G G Belz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4277032     DOI: 10.1007/bf00500991

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  9 in total

1.  Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin.

Authors:  T W Smith; V P Butler; E Haber
Journal:  Biochemistry       Date:  1970-01-20       Impact factor: 3.162

2.  Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.

Authors:  R W Albers; G J Koval
Journal:  Mol Pharmacol       Date:  1968-07       Impact factor: 4.436

3.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

4.  Characterization and specificity of proscillaridin antibodies.

Authors:  G G Belz; W J Brech; U R Kleeberg; G Rudofsky; G Belz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Serum cardiac glycoside assay based upon displacement of 3 H-ouabain from Na-K ATPase.

Authors:  G Brooker; R W Jelliffe
Journal:  Circulation       Date:  1972-01       Impact factor: 29.690

6.  Ouabain-induced ventricular arrhythmia in rabbit: influence of antibodies.

Authors:  F Ciofalo; H Ashe
Journal:  Life Sci I       Date:  1971-03-15

7.  Ouabain-specific antibodies: immunochemical properties and reversal of Na + , K + -activated adenosine triphosphatase inhibition.

Authors:  T W Smith
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

8.  The measurement of digitoxin in human serum by radioimmunoassay.

Authors:  G C Oliver; B M Parker; D L Brasfield; C W Parker
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

9.  Immunological protecion against dixin toxicity.

Authors:  D H Schmidt; V P Butler
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.